GE sells biopharma unit in major $21.4B deal

In an effort to return to its industrial roots, General Electric has sold its biopharmaceutical business to Danahar Corp. for $21.4 billion.

Source: PharmaManufacturing.com - February 25, 2019 Category: Pharmaceuticals Source Type: news